Cate Lawrence
Senior Writer at Tech.eu
@catelawrence.bsky.social Senior writer at @tech_eu Email pitches to [email protected]
Articles
-
1 week ago |
tech.eu | Cate Lawrence
AI productivity assistant Grammarly has raised $1 billion financing from General Catalyst. Founded in 2009 in Ukraine, Grammarly's funding has grown to over $1.4 billion. Grammarly is considered adecacorn, a privately held startup valued at over $10 billion. The company continues to be profitable, generating annual revenues surpassing $700 million. More than 40 million users rely on Grammarly daily, contributing to Grammarly’s annual revenue of more than $700 million.
-
1 week ago |
tech.eu | Cate Lawrence
Today, the European Commission adopted the EU Startup and Scaleup Strategy. The strategy aligns with the broader ‘Choose Europe' initiative, launched by President von der Leyen. It drives forward calls for reforms by Mario Draghi, Enrico Letta, EU Commission President Ursula von der Leyen, EU Inc, and Not Optional to address innovation and competitiveness in Europe.
-
1 week ago |
tech.eu | Cate Lawrence
Aside from the pain of stepping on a Lego barefoot in the middle of the night, few things are worse in Legoland than nearly finishing a build only to realise a piece is missing. Fortunately, Lithuanian startup Sort A Brick has you covered. It offers a service that cleans, sorts, and repackages customers’ LEGO bricks into original or custom sets, giving second lives to already-owned toys. I spoke to co-founder Ilya Malkin to learn more.
-
1 week ago |
tech.eu | Cate Lawrence
One of the biggest challenges facing biologic drug developers are varying efficacy and the dangers of side effects. Biotechnology company Kyron.bio has raised €5.5 million funding to solve these issues using precise control of sugar molecules found on the surface of a drug — also known as glycans. One of the major problems with antibody therapeutics is the patient's immune system recognising the treatment as foreign and attacking it.
-
1 week ago |
tech.eu | Cate Lawrence
Danish medtech company Brainreader has raised €6.6 million to accelerate the global rollout of its AI-driven diagnostic platform Neuroreader. Neuroreader is a CE-marked and FDA-cleared software platform that delivers automated volumetric analysis of brain MRI scans. Used by radiologists and neurologists in clinical practice, it aids in the diagnosis and monitoring of neurological conditions such as Alzheimer’s disease, traumatic brain injury, and other neurodegenerative disorders.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 4K
- Tweets
- 37K
- DMs Open
- No
same
I was around 9 or 10 wearing my school uniform when I was catcalled by grown men for the first time. Did I invite a certain type of energy? Like are YOU okay? https://t.co/uROn5UrTZg
In case you need reminding
For three years Australia has proudly supported the brave people of Ukraine in their struggle to defend their sovereignty against the brutality of Russian aggression and in support of international law. Australia stands with Ukraine. 🇦🇺🇺🇦
RT @_FriedrichMerz: Dear Volodymyr @zelenskyyua, we stand with #Ukraine in good and in testing times. We must never confuse aggressor and v…
